Table 1.
Parameter | Number | CENPA mRNA expression | P-value | |
---|---|---|---|---|
Low (n = 261) | High (n = 261) | |||
Age (years) | ||||
< 60 | 235 | 120 | 115 | 0.725 |
≥ 60 | 287 | 141 | 146 | |
Sex | ||||
Female | 183 | 108 | 75 | 0.0033 |
Male | 339 | 153 | 186 | |
T stage | ||||
T1 or T2 | 336 | 197 | 139 | < 0.0001 |
T3 or T4 | 186 | 64 | 122 | |
N Stage | ||||
N0 or Nx | 507 | 258 | 249 | 0.0326 |
N1 | 15 | 3 | 12 | |
M Stage | ||||
M0 or Mx | 445 | 242 | 203 | < 0.0001 |
M1 | 77 | 19 | 58 | |
G grade | ||||
G1 or G2 or Gx | 245 | 157 | 88 | < 0.0001 |
G3 or G4 | 277 | 104 | 173 | |
TNM stage | ||||
I + II | 318 | 190 | 128 | < 0.0001 |
III + IV | 204 | 71 | 133 |
The four-grid tables were made according to clinicopathological characteristics and the CENPA expression level. Statistical analyses were conducted via Pearson's χ2 test. P < 0.05 was considered statistically significant